Can MUSE Cells Help a Damaged Kidney?
Early laboratory and animal studies suggest MUSE cells can reach damaged kidney tissue, but this is still investigational in people. Chronic kidney disease affects hundreds of millions of people worldwide, according to the Global Burden of Disease kidney study, and many live with tiredness, swelling and regular blood tests.
Why Standard Kidney Care Comes First
Blood pressure control, blood sugar control in diabetes, kidney-protecting medicines and diet advice slow the disease for many people. Any regenerative option sits alongside this care, never instead of it.
What MUSE Cell Kidney Studies Show So Far
Uchida and colleagues, working with Dezawa's team in 2017, gave human MUSE cells into a vein in mice with adriamycin-induced FSGS. The cells gathered in damaged glomeruli (kidney filters), formed cells with filter-cell markers, and were linked with less scarring and better creatinine clearance. In mice with normal immune systems, the benefit faded by week 7 due to immune rejection.
A 2018 review by the same group outlines the potential of MUSE cells for kidney disease. These are animal findings, and human kidney trials are still needed.
Standard Kidney Care and MUSE Research Compared
| Feature | Standard kidney care | MUSE cell therapy |
|---|---|---|
| Status | Established | Investigational |
| Main aim | Slow decline, protect function | Explore tissue repair |
| Evidence | Large human trials | Mainly animal studies |
| Role | Foundation of care | Possible addition after review |
MUSE Cell Therapy Approach for Kidney Concerns
At our healthcare facility, a doctor first reviews your kidney results and your nephrologist's plan. If MUSE cell therapy is discussed, we explain it clearly as investigational, describe how cells are prepared and tested, and coordinate with your home doctor. Learn how MUSE cells are isolated and quality tested, and how MUSE research compares in liver cirrhosis.
Questions to Ask Your Kidney Doctor
- What stage is my kidney disease?
- Is my eGFR stable or changing?
- Are my blood pressure and sugar on target?
- Would a new treatment affect my medicines?
- Can you share my records with another team?
Medical References
- GBD Chronic Kidney Disease Collaboration, 2020. Global, regional, and national burden of chronic kidney disease, 1990-2017
- Uchida N and colleagues, 2017. Beneficial effects of systemically administered human Muse cells in adriamycin nephropathy
- Uchida N and colleagues, 2018. Application of Muse cell therapy for kidney diseases
Talk to a Doctor Before You Decide
Living with kidney disease and curious about MUSE cell research? Share your records and our team will give you an honest review.
Schedule a Consultation





